ArticleInternational journal of clinical oncology2025

A single-center retrospective study of dabrafenib plus trametinib combination therapy in patients with BRAF V600E-positive thyroid cancer.

Taiju Ando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.